Literature DB >> 19554975

Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.

M Avijgan1, R Habibian, S Kheiri.   

Abstract

The current target groups for measles, mumps and rubella vaccination in the Islamic Republic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalenceRepublic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalence of antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the needof antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the need for booster vaccinations to cover non-immune children. Of 338 children, 19.8% were seronegative. Age-specific seronegativity was 33.3%, 20.5% and 4.6% in age groups 7-11, 12-14 and 15-18 years respectively. To obtain herd immunity, we suggest that for the next 5 years children aged 7-11 years entering guidance school are selected as the main group for vaccination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554975

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  1 in total

1.  A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents.

Authors:  Zary Nokhodian; Behrooz Ataei; Mohammad Mehdi Gouya; Shervin Ghaffari Hoseini; Majid Yaran; Marjan Mansourian; Mohammad Esmaeil Motlagh; Ramin Heshmat; Seyed Mohsen Zahraei; Roya Kelishadi
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.